Skip to content
HowShorted

Novavax, Inc. short interest in 2023

In 2023, Novavax, Inc.'s disclosed short interest ran from 39.37% of shares outstanding on 13 Jan 2023 to 41.41% on 29 Dec 2023, a change of +2.04 percentage points. The year's high was 47.13% on 15 Sep 2023 and its low 34.64% on 15 Nov 2023, averaging 40.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.15 days on 31 Jul 2023. Full history: Novavax, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Novavax, Inc. in 2023

2023 in figures

Start of year
39.37% (13 Jan 2023)
End of year
41.41% (29 Dec 2023)
Change
+2.04 pp
High
47.13% (15 Sep 2023)
Low
34.64% (15 Nov 2023)
Average
40.18%
Highest days to cover
8.15 (31 Jul 2023)
SEC filings marked
8

Every report in 2023

Novavax, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202339.37%3.78
31 Jan 202339.28%4.97
15 Feb 202340.83%5.55
28 Feb 202339.58%6.2710-K filed, results (8-K)
15 Mar 202338.58%3.91
31 Mar 202343.83%7.49
14 Apr 202339.63%5.44
28 Apr 202338.99%6.92
15 May 202336.99%3.9810-Q filed, results (8-K)
31 May 202334.80%6.09
15 Jun 202335.73%5.60
30 Jun 202342.23%5.76
14 Jul 202342.51%4.66
31 Jul 202339.14%8.15
15 Aug 202342.16%4.5210-Q filed, results (8-K)
31 Aug 202342.46%3.91
15 Sep 202347.13%2.89
29 Sep 202347.07%5.63
13 Oct 202345.54%3.90
31 Oct 202337.81%7.02
15 Nov 202334.64%6.7310-Q filed, results (8-K)
30 Nov 202336.29%7.97
15 Dec 202338.34%5.20
29 Dec 202341.41%5.88

See also: Novavax, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.